Epigenetic reader domain inhibitor BI-9564, Purity ≥98%

Cat. No.: X24-05-ZQ425

Epigenetic reader domain inhibitor BI-9564, Purity ≥98%

Synonym: 1883429-22-8; BI 9564; BI9564; Epigenetic reader domain inhibitor

  • CAS Number: 1883429-22-8
  • Compound CID: 117072549
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BI-9564, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD7, BRD9, and CECR2.
Molecular Weight
353.41
Molecular Formula
C20H23N3O3
Targets
BRD7: 73 nM (Kd); BRD9: 5.9 nM (Kd); CECR2: 77 nM (Kd)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 3 mg/mL (8.48 mM); Water: Insoluble; Ethanol: 15 mg/mL (42.44 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BI-9564 can be used to study the inhibition of specific bromodomains, contributing to research on gene regulation and disease.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0